Comparative analysis of a liquid-based pap test and concurrent HPV DNA assay of residual samples: A study of 608 cases

Acta Cytologica

Volumn 46, Issue 5, 2002, Pages 828-834

  Hong, In Soon ^a   Marshalleck, Josephine ^a   Williams, Robert H ^a   Gaiter, Thomas E ^a   Mielzynska Lohnas, Iwona ^a   Kim, Kyungsook ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical smears; Cervix neoplasms; Hybrid Capture System II; Mass screening; Papillomavirus, human; Quality improvement; ThinPrep Pap Test

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0036736660     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000327055     Document Type: Article

References (20)

1. Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299
2. Wright TC, Goldie SJ, Cain JM, Howett MK: Screening for cervical cancer. Science 2000;290:1651
3. Birner P, Schindl M, Stani J, Oberhuber G, Czerwenka K, Vutuc C, Breitenecker G: Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology. Wien Klin Wochenschr 2000;112:761-766
4. Koss LG: Human papillomavirus testing as a screening tool for cervical cancer. JAMA 2000;283:2525-2526
5. Cuzick J: Human papillomavirus testing for primary cervical cancer screening. JAMA 2000;283:108-109
6. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlic GF, Hiatt RA: Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281: 1605-1610
7. Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M: Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 1997;81:89-97
8. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ: Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-954
9. Ferenczy A, Franco E, Arseneau J, Wright TC, Richart RM: Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol 1996;175: 651-656
10. Vassilakos P, de Marval F, Munoz M, Broquet G, Campana A: Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear. Int J Gynaecol Obstet 1998;61:45-50
11. Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Woodward L: Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear report of ASCUS and LSIL. J Fam Pract 1998;46:136-141
12. Clavel C, Masure M, Levert M, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Cabriel R, Quereux C, Birembaut P: Human papillomavirus detection by the hybrid capture II assay: A reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol 2000;9:145-150
13. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Law KS: High-risk HPV DNA detection by Hybrid Capture II: An adjunctive test for mildly abnormal cytologic smears in women ≥ 50 years of age. J Reprod Med 2000;45:345-350
14. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, van Ballegooijen M, Van Den Akker E: A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3:1-204
15. Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan W-K, Krausz T, Soutter P: HPV testing in primary screening of older women. Br J Cancer 1999;81:554-558
16. Digene Hybrid Capture® System, Cytyc ThinPrep® Pap Test, PreservCyt® Solution. Gaithersburg, Maryland, U.S.A., Digene Corporation, 1998, pp 8-10
17. Gupta D, Kannan V, Komaromy-Hiller G, Kline TS: ASCUS, mature metaplastic type: Cytologic diagnosis and follow-up. Acta Cytol 2001;45:192-196
18. Zuna RE, Moor W, Dunn ST: HPV DNA testing of the residual sample of liquid-based Pap test: Utility as a quality assurance monitor. Mod Pathol 2001;14:147-151
19. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ: Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805
20. Ramesar JE, Dehaeck CM, Soeters R, Williamson AL: Human papillomavirus in normal cervical smears from Cape Town. S Afr Med J 1996;86:1402-1405